Pulmatrix (PULM) Asset Utilization Ratio (2014 - 2024)
Pulmatrix (PULM) posted Asset Utilization Ratio of 0.73 for Q4 2024, down 0.75% sequentially from 0.73 in Q3 2024, and up 252.64% YoY from 0.21 in Q1 2024.
Pulmatrix (PULM) Asset Utilization Ratio (2014 - 2024) Analysis & Trends
Pulmatrix has reported Asset Utilization Ratio for 11 years, with the latest figure at 0.73 in Q4 2024.
- Quarterly Asset Utilization Ratio rose 252.64% year-over-year to 0.73 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.73 (up 252.64% YoY) and the FY2024 annual result came in at 0.36, up 82.51% from the prior year.
- Asset Utilization Ratio retreated to 0.73 in Q4 2024 per PULM's latest filing, from 0.73 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.73 in Q3 2024 and troughed at 0.08 in Q2 2022.
- A 5-year average of 0.26 and a median of 0.21 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio tumbled 71.06% in 2021, then surged 267.28% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.31 in 2020, then sank by 71.06% to 0.09 in 2021, then jumped by 53.95% to 0.14 in 2022, then soared by 48.55% to 0.21 in 2023, then soared by 252.64% to 0.73 in 2024.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.73, 0.73, and 0.49 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.13 |
| 10 | Pulmatrix | 5.62 Mn | 5.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.73 |
| Jun 30, 2024 | 0.49 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 0.20 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | 0.17 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.10 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.15 |
| Mar 31, 2021 | 0.21 |
| Dec 31, 2020 | 0.31 |
| Sep 30, 2020 | 0.32 |
| Jun 30, 2020 | 0.28 |
| Mar 31, 2020 | 0.32 |